• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

转移性胰腺神经内分泌肿瘤分泌甲状旁腺激素相关肽导致的难治性高钙血症:一例报告

Refractory hypercalcemia caused by parathyroid-hormone-related peptide secretion from a metastatic pancreatic neuroendocrine tumor: a case report.

作者信息

Haimi Motti, Yang Ji Wei, Kremer Richard

机构信息

Meuhedet Health Services, Northern District, Israel.

Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, 3109601, Haifa, Israel.

出版信息

J Med Case Rep. 2025 Feb 10;19(1):54. doi: 10.1186/s13256-025-05074-9.

DOI:10.1186/s13256-025-05074-9
PMID:39924477
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11809048/
Abstract

BACKGROUND

The parathyroid-hormone-related peptide has been shown in earlier studies to be secreted by pancreatic neuroendocrine tumors, although its secretion by gastroenteropancreatic neuroendocrine tumors is very rare. In contrast, a number of solid tumors, such as lung cancer and renal cell carcinoma, have frequently been shown to secrete parathyroid-hormone-related peptide.

CASE PRESENTATION

We describe a case report of a 53-year-old Canadian white patient with refractory parathyroid-hormone-related-peptide-mediated hypercalcemia associated with metastatic pancreatic neuroendocrine tumors and review the available research. Our patient had severe hypercalcemia initially refractory to treatment. Computed tomography scan of the abdomen revealed a pancreatic lesion and multiple hepatic metastases. A liver biopsy confirmed metastatic pancreatic neuroendocrine tumor expressing parathyroid-hormone-related peptide. Circulating parathyroid-hormone-related peptide levels were at the upper limit of normal preoperatively and decreased sharply postoperatively following debulking of the tumor. Blood calcium levels eventually normalized on long-term administration of the somatostatin analog lanreotide in combination with denosumab.

CONCLUSIONS

We describe a case with parathyroid-hormone-related-peptide-mediated hypercalcemia in a pancreatic neuroendocrine tumor (parathyroid-hormone-related peptide tumor). Refractory hypercalcemia was likely the result of parathyroid-hormone-related peptide overproduction by the tumor and resolved following normalization of parathyroid-hormone-related peptide levels.

摘要

背景

早期研究表明,甲状旁腺激素相关肽由胰腺神经内分泌肿瘤分泌,尽管胃肠胰神经内分泌肿瘤分泌该肽的情况极为罕见。相比之下,许多实体瘤,如肺癌和肾细胞癌,常被证明可分泌甲状旁腺激素相关肽。

病例报告

我们描述了一例53岁加拿大白人患者,其患有与转移性胰腺神经内分泌肿瘤相关的难治性甲状旁腺激素相关肽介导的高钙血症,并回顾了现有研究。我们的患者最初患有严重的高钙血症,对治疗难治。腹部计算机断层扫描显示胰腺有病变和多处肝转移。肝活检证实为转移性胰腺神经内分泌肿瘤,表达甲状旁腺激素相关肽。术前循环中的甲状旁腺激素相关肽水平处于正常上限,肿瘤减瘤术后急剧下降。长期给予生长抑素类似物兰瑞肽联合地诺单抗后,血钙水平最终恢复正常。

结论

我们描述了一例胰腺神经内分泌肿瘤(甲状旁腺激素相关肽肿瘤)中甲状旁腺激素相关肽介导的高钙血症病例。难治性高钙血症可能是肿瘤过度产生甲状旁腺激素相关肽的结果,在甲状旁腺激素相关肽水平恢复正常后得以解决。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7ce/11809048/bcb466ad3c16/13256_2025_5074_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7ce/11809048/bcb466ad3c16/13256_2025_5074_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7ce/11809048/bcb466ad3c16/13256_2025_5074_Fig1_HTML.jpg

相似文献

1
Refractory hypercalcemia caused by parathyroid-hormone-related peptide secretion from a metastatic pancreatic neuroendocrine tumor: a case report.转移性胰腺神经内分泌肿瘤分泌甲状旁腺激素相关肽导致的难治性高钙血症:一例报告
J Med Case Rep. 2025 Feb 10;19(1):54. doi: 10.1186/s13256-025-05074-9.
2
Case report: lanreotide in the management of hypercalcemia of malignancy.病例报告:兰瑞肽用于治疗恶性肿瘤高钙血症
Am J Med Sci. 1995 Jun;309(6):312-4. doi: 10.1097/00000441-199506000-00002.
3
Case report of multimodality treatment for metastatic parathyroid hormone-related peptide-secreting pancreatic neuroendocrine tumour.转移性甲状旁腺激素相关肽分泌性胰腺神经内分泌肿瘤的多模态治疗病例报告
Tumori. 2014 Jul-Aug;100(4):153e-6e. doi: 10.1700/1636.17936.
4
Case Report: Unmasking Hypercalcemia in Patients With Neuroendocrine Neoplasms. Experience From Six Italian Referral Centers.病例报告:揭示神经内分泌肿瘤患者高钙血症。来自六个意大利转诊中心的经验。
Front Endocrinol (Lausanne). 2021 May 19;12:665698. doi: 10.3389/fendo.2021.665698. eCollection 2021.
5
Peptide receptor radionuclide therapy controls inappropriate calcitriol secretion in a pancreatic neuro-endocrine tumor: a case report.肽受体放射性核素治疗控制胰腺神经内分泌肿瘤中不适当的骨化三醇分泌:一例报告
BMC Gastroenterol. 2020 Oct 2;20(1):324. doi: 10.1186/s12876-020-01470-1.
6
Humoral hypercalcemia of malignancy caused by parathyroid hormone-related peptide-secreting neuroendocrine tumors. Report of six cases.由甲状旁腺激素相关肽分泌的神经内分泌肿瘤引起的恶性肿瘤所致体液性高钙血症。六例报告。
Pancreatology. 2013 May-Jun;13(3):324-6. doi: 10.1016/j.pan.2013.02.007. Epub 2013 Mar 1.
7
Severe hypercalcemia due to metastatic pancreatic neuroendocrine tumor: a case report.转移性胰腺神经内分泌瘤导致的严重高钙血症:一例报告。
J Med Case Rep. 2023 Sep 6;17(1):400. doi: 10.1186/s13256-023-04042-5.
8
Parathyroid Hormone-Related Peptide Secretion From a Pancreatic Neuroendocrine Tumor: A Rare Case Report of Severe Hypercalcemia.胰腺神经内分泌肿瘤分泌甲状旁腺激素相关肽:一例严重高钙血症的罕见病例报告
AACE Clin Case Rep. 2024 May 4;10(4):160-163. doi: 10.1016/j.aace.2024.04.009. eCollection 2024 Jul-Aug.
9
Hypercalcemia of malignancy caused by parathyroid hormone-related peptide-secreting pancreatic neuroendocrine tumors (PTHrP-PNETs): Case Report.由分泌甲状旁腺激素相关肽的胰腺神经内分泌肿瘤(PTHrP-PNETs)引起的恶性肿瘤高钙血症:病例报告
Front Oncol. 2023 Jun 12;13:1197288. doi: 10.3389/fonc.2023.1197288. eCollection 2023.
10
Reversal of Severe and Refractory Humoral Hypercalcemia With 177Lu-Octreotate Peptide Receptor Radionuclide Therapy for Neuroendocrine Tumor of the Pancreas.177Lu-奥曲肽肽受体放射性核素治疗胰腺神经内分泌肿瘤致严重难治性体液性高钙血症逆转。
Clin Nucl Med. 2015 Sep;40(9):e448-50. doi: 10.1097/RLU.0000000000000862.

本文引用的文献

1
Hypercalcemia of malignancy caused by parathyroid hormone-related peptide-secreting pancreatic neuroendocrine tumors (PTHrP-PNETs): Case Report.由分泌甲状旁腺激素相关肽的胰腺神经内分泌肿瘤(PTHrP-PNETs)引起的恶性肿瘤高钙血症:病例报告
Front Oncol. 2023 Jun 12;13:1197288. doi: 10.3389/fonc.2023.1197288. eCollection 2023.
2
Immunoarray Measurements of Parathyroid Hormone-Related Peptides Combined with Other Biomarkers to Diagnose Aggressive Prostate Cancer.免疫阵列检测甲状旁腺激素相关肽与其他生物标志物联合用于诊断侵袭性前列腺癌。
Anal Chem. 2022 Sep 20;94(37):12788-12797. doi: 10.1021/acs.analchem.2c02648. Epub 2022 Sep 8.
3
Parathyroid hormone-related protein (PTHrP) and malignancy.
甲状旁腺激素相关蛋白(PTHrP)与恶性肿瘤
Vitam Horm. 2022;120:133-177. doi: 10.1016/bs.vh.2022.03.002. Epub 2022 Jul 25.
4
PTHrP Drives Pancreatic Cancer Growth and Metastasis and Reveals a New Therapeutic Vulnerability.甲状旁腺激素相关蛋白促进胰腺癌生长和转移,并揭示了新的治疗靶点。
Cancer Discov. 2021 Jul;11(7):1774-1791. doi: 10.1158/2159-8290.CD-20-1098. Epub 2021 Feb 15.
5
PTHrP, A Biomarker for CNS Metastasis in Triple-Negative Breast Cancer and Selection for Adjuvant Chemotherapy in Node-Negative Disease.甲状旁腺激素相关蛋白,三阴性乳腺癌中枢神经系统转移的生物标志物及淋巴结阴性疾病辅助化疗的选择指标
JNCI Cancer Spectr. 2019 Aug 29;4(1):pkz063. doi: 10.1093/jncics/pkz063. eCollection 2020 Feb.
6
Phase 3 Trial of Lu-Dotatate for Midgut Neuroendocrine Tumors.镥[177Lu]奥曲肽治疗中肠神经内分泌肿瘤的3期试验
N Engl J Med. 2017 Jan 12;376(2):125-135. doi: 10.1056/NEJMoa1607427.
7
Cancer Diagnostics via Ultrasensitive Multiplexed Detection of Parathyroid Hormone-Related Peptides with a Microfluidic Immunoarray.基于微流控免疫芯片对甲状旁腺激素相关肽进行超灵敏多重检测的癌症诊断。
Anal Chem. 2016 Sep 20;88(18):9269-75. doi: 10.1021/acs.analchem.6b02637. Epub 2016 Sep 8.
8
The Role of Capecitabine/Temozolomide in Metastatic Neuroendocrine Tumors.卡培他滨/替莫唑胺在转移性神经内分泌肿瘤中的作用
Oncologist. 2016 Jun;21(6):671-5. doi: 10.1634/theoncologist.2015-0470. Epub 2016 May 25.
9
Clinical features of pancreatic neuroendocrine tumors.胰腺神经内分泌肿瘤的临床特征
J Hepatobiliary Pancreat Sci. 2015 Aug;22(8):578-85. doi: 10.1002/jhbp.226. Epub 2015 Feb 17.
10
Biotherapy of pancreatic neuroendocrine tumors using somatostatin analogs.使用生长抑素类似物对胰腺神经内分泌肿瘤进行生物治疗。
J Hepatobiliary Pancreat Sci. 2015 Aug;22(8):618-22. doi: 10.1002/jhbp.227. Epub 2015 Feb 16.